Patient Center
Infusion therapy is a convenient and effective option to treat conditions that are difficult or impossible to treat with other forms of medication. Infusions can drastically increase your everyday well-being.
Michiana infusions offers outpatient infusion treatment for various chronic conditions including migraines. MS, NMOSD, and more. With every medication there is the risk of adverse side effects. Our staff will inform you of the risks of your infusion prior to the start of your treatment.
How to Ask for a Referral
Please ask your healthcare provider to send us a completed medication order form, clinical notes, demographics, and your insurance card, via fax, to (574) 252-7796.
Providers can find medication order forms by clicking here.
A team member will contact the referring provider and confirm the referral receipt.
We will then take care of any necessary administrative tasks and contact you to schedule an appointment.
Ready for an Appointment?
Appointments can be requested by phone from 8:30 AM – 12:00 PM and 1:00 PM – 4:30 PM, or by clicking the button below.
New Patient? Click here to download our New Patient Paperwork, so you can be one step ahead at your first appointment
Treatment Options
Preventative and Acute Migraine Infusion
Migraines remain one of the most prevalent conditions that can be treated with infusion therapy. At Michiana Infusions, we offer a personalized infusion that deals with migraines. This migraine cocktail is determined based on the triggers of your specific migraine, and can be personalized to deal with many different types of migraines.
Ocrevus®
Ocrevus® is a prescription intravenous treatment specifically designed for adults with relapsing forms of multiple sclerosis (MS), encompassing both relapsing-remitting MS (RMS) and secondary progressive MS (SPMS). Ocrevus® is the only FDA-approved medication for primary progressive MS. This treatment works by targeting and depleting specific B cells in the immune system, playing a crucial role in minimizing the impact of the disease on nerve cells.
Briumvi®
Briumvi® offers a practical breakthrough in the field of multiple sclerosis (MS) treatment, as the only FDA-approved one-hour, twice-a-year infusion tailored for relapsing MS (RMS). This B-cell therapy effectively addresses RMS, demonstrating a notable reduction in brain lesions and affirming its positive impact on disease progression. Briumvi® is only administered once every six months, making it an extremely practical solution for MS treatment.
Soliris®
Soliris® is an FDA-approved medication primarily used for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disorder. Soliris® works by inhibiting the breakdown of red blood cells, which is a characteristic feature of PNH. This innovative treatment has been instrumental in improving the quality of life for individuals affected by PNH, offering a targeted and effective solution to manage the condition.
UPLIZNA®
UPLIZNA® is an FDA-approved medication specifically designed for the treatment of neuromyelitis optica spectrum disorder (NMOSD). This autoimmune disorder affects the central nervous system, leading to inflammation of the optic nerve and spinal cord. UPLIZNA® has shown efficacy in preventing relapses and managing the symptoms associated with NMOSD, providing a valuable treatment option for individuals diagnosed with this condition.
Ultomiris®
Ultomiris® is a prescription medication tailored for adults with generalized myathenia gravis (gMG) who test positive for the AChR antibody. This unique treatment offers a streamlined approach, requiring only a 30 minutes-one hour infusion administered once every 8 weeks. The simplicity of Ultomiris® administration, combined with its efficacy in managing gMG symptoms, underscores its significance in providing accessible and efficient care for individuals dealing with this autoimmune disorder.
Vyepti®
Vyepti® is an advanced migraine treatment that has shown exceptional results in enhancing the quality of life for those dealing with chronic migrianes. Administered through 30-minute IV sessions once every three months. Vyepti® reduces migraine days by as many as 23 over a three-month span and 75% fewer migraine days at the six-month mark. Notably, many patients experience migraine-free days within the first week post-treatment. With 1615 patient years of exposure, Vyepti® is a reliable option in migriane management, exemplifying both safety and efficacy. Michiana Infusions is dedicated to providing a supportive and professional environment for individuals seeking migraine relief through Vyepti® infusions.
Tysabri®
At Michiana Infusions we offer Tysabri®, a prescription infusion medication crafted to treat Multiple Sclerosis (MS). Tysabri® is tailored to treat various MS phases, including clinically isolated syndrome, relapsing-remitting disease, and active secondary disease. Tysabri® operates by targeting specific immune system components to alleviate inflammation in the central nervous system. Reflecting our commitment to patient-centered care, our experienced healhtcare team collaborates closely with individuals to personalize Tysabri® treatments, providing a vital bridge to improved health and enhanced quality of life for those navigating the complexities of MS.
VYVGART®
VYVGART® serves as a prescription medication targeted at alleviating the symptoms of myasthenia gravis (gMG), a persistent autoimmune disease impacting the skeletal muscles in adults with the AChR antibody. This treatment provides relief for individuals suffering from gMG, contributing to improved muscle function and enhancing overall quality of life. Administered under medical guidance, VYVGART® stands as a reliable and effective solution, offering hope and support to those navigating the complexities of this autoimmune disorder.